Yüksel Ürün, Medical Oncology Professor at Ankara University School of Medicine, shared a post on X:
“In a cohort of 86,632 adults with obesity, GLP-1 receptor agonists were linked to lower overall cancer risk.
- Notably decreased risk: endometrial, ovarian, meningioma.
- But signal for increased kidney cancer risk.
Balance of benefit and caution.”
Title: GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity
Authors: Hao Dai, Yongqiu Li, Yao An Lee, Ying Lu, Thomas J. George, William T. Donahoo, Kelvin P. Lee, Harikrishna Nakshatri, John Allen, Yi Guo, Ramon C. Sun, Jingchuan Guo, Jiang Bian
Read the Full Article.
More posts featuring Yüksel Ürün.